Dibutylone (bk-DMBDB[2]) is a stimulant drug of the amphetamine, phenethylamine, cathinone, and phenylisobutylamine families. It is structurally related to butylone, a designer drug that has been detected in products marketed as bath salts or plant food.[3]
In 2018, dibutylone was the third most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures.[4]
Legal status
In United States, dibutylone is on the list of Schedule I Controlled Substances as a positional isomer of pentylone.[5]
References
- ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
- ^ "Southern Association of Forensic Scientists". Archived from the original on 2013-03-25. Retrieved 2012-12-12.
- ^ Krotulski, Alex J; Mohr, Amanda L A; Papsun, Donna M; Logan, Barry K (2018). "Dibutylone (bk-DMBDB): Intoxications, Quantitative Confirmations and Metabolism in Authentic Biological Specimens". Journal of Analytical Toxicology. 42 (7): 437–445. doi:10.1093/jat/bky022. PMID 29554274.
- ^ "Emerging Threat Report: Annual 2018" (PDF). Special Testing and Research Laboratory, Drug Enforcement Administration.
- ^ "Controlled Substances" (PDF). Drug Enforcement Administration.
You must be logged in to post a comment.